Follow us on LinkedIn - https://www.linkedin.com/company/fatty-liver-alliance/
Welcome to FLA on the road! Our first guest is Dr. Supriya Joshi, Hepatologist and we discuss fast food nutrition and the impact on liver health.
It is very clear that one specialist alone cannot offer all the medical care a NASH patient will need. It is time for a multidisciplinary, team approach. How will that work? Is it already happening? Watch this engaging discussion with Dr. Kenneth, Endocrinologist, Dr. Mark Swain, Hepatologist and Dr. Ming Jun, Primary Care Physician focused on hepatology.
Make sure to watch this informative discussion about non-invasive liver tests (NITs). Two experts in liver NITs will share their experience and knowledge about the latest trends and advancements. Thank you Dr. Imtiaz Alam and Dr. Mona Munteanu for some really insightful sessions with Michael Betel. Learn about the differences between NITs and more about the future of liver biopsies.
This highly interactive discussion between Endocrinologist, Dr. Kenneth Cusi, Dr. Mark Swain, Hepatologist and Michael Betel exploring the topic of obesity, type-2 diabetes and fatty liver disease.
Roger Green, President of Hep Dynamics, has been forecasting the NASH Tsunami on his podcast and enlightened listeners from around the world. Watch as Roger and Michael Betel discuss the backstory and outlook for NAFLD and NASH in 2022.
Join Dr. Naim Alkhouri, Dr. Mark Swain and Michael Betel as they discuss all the great advances in NAFLD and NASH in 2021!
Dr. Manal Abdelmalek, Hepatologist from Duke University shares her insights in the NAFLD/NASH landscape from 2021, with Michael Betel.
Dr. Mohit Kehar shares insights from the AASLD, TLMdX2021 conference - the importance of screening children for fatty liver disease.
Dr. Naim Alkhouri discusses NAFLD and NASH, risks and recommendations,
Dr. Nadege Gunn discusses the myths of clinical trials (part 1).
Dr. Nadege Gunn discusses the myths of clinical trials (part 2).
An encore fireside chat about NAFLD and NASH with Drs. Tracey Simon, Naim Alkhouri, and Mark Swain
Drs. Tracey Simon, Naim Alkhouri, and Mark Swain discuss the mortality impact of NAFLD.
The creator of the FIB-4 liver assessment tool, Dr. Richard Sterling shares the background story of how this very popular tool was created and why.
Dr. Naim Alkhouri discusses NAFLD and NASH incidence being much higher than estimates.
Dr. Mark Swain shares advice for liver patients during the Covid-19 pandemic.
Dr. Robert Gish and the Weight Loss Roadmap
Dr. Giada Sebastiani discusses the silent epidemic of NAFLD.
Dr. Giada Sebastiani discusses the best diet for NAFLD and NASH patients.
Dr. Supriya Joshi discusses the importance of eating well to prevent or address NAFLD and NASH. Avoidance of sugar is a critical focus area.